Pell Bio-Med Technology Co., Ltd.
Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications. Its commercial products include good tissue practice laboratory infrastructure, adipose-derived stem cells (ADSC) for regenerative medicine, and CIK and DC-CIK against cancers. The company also develops medicines for various types of cancers… Read more
Market Cap & Net Worth: Pell Bio-Med Technology Co., Ltd. (6949)
Pell Bio-Med Technology Co., Ltd. (TW:6949) has a market capitalization of $1.02 Billion (NT$33.73 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #10191 globally and #278 in its home market, demonstrating a -2.88% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pell Bio-Med Technology Co., Ltd.'s stock price NT$574.00 by its total outstanding shares 58757550 (58.76 Million).
Pell Bio-Med Technology Co., Ltd. Market Cap History: 2025 to 2026
Pell Bio-Med Technology Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $608.24 Million to $1.02 Billion (0.00% CAGR).
Pell Bio-Med Technology Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pell Bio-Med Technology Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6949 by Market Capitalization
Companies near Pell Bio-Med Technology Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Pell Bio-Med Technology Co., Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Pell Bio-Med Technology Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, Pell Bio-Med Technology Co., Ltd.'s market cap moved from $608.24 Million to $ 1.02 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$1.02 Billion | +67.59% |
| 2025 | NT$608.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pell Bio-Med Technology Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.02 Billion USD |
| MoneyControl | $1.02 Billion USD |
| MarketWatch | $1.02 Billion USD |
| marketcap.company | $1.02 Billion USD |
| Reuters | $1.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.